Skin Cancer

Oncology
0
Pipeline Programs
2
Companies
6
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alpha Tau Medical
Alpha Tau MedicalJERUSALEM, Israel
5 programs
Device: Radiation: Diffusing Alpha Radiation Emitters TherapyN/A1 trial
Radiation: Diffusing Alpha Radiation Emitters TherapyN/A1 trial
Radiation: Diffusing Alpha Radiation Emitters TherapyN/A1 trial
Radiation: Diffusing Alpha Radiation Emitters TherapyN/A1 trial
Radiation: Diffusing Alpha Radiation Emitters TherapyN/A1 trial
Active Trials
NCT03886181Terminated2Est. Oct 2024
NCT03737734Active Not Recruiting30Est. Dec 2025
NCT04540588Completed2Est. Dec 2025
+2 more trials
ProgenaBiome
ProgenaBiomeCA - Ventura
1 program
Non-interventionalN/A1 trial
Active Trials
NCT04099446WithdrawnEst. Dec 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alpha Tau MedicalDevice: Radiation: Diffusing Alpha Radiation Emitters Therapy
Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy
Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy
Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy
ProgenaBiomeNon-interventional
Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy

Clinical Trials (6)

Total enrollment: 120 patients across 6 trials

NCT03886181Alpha Tau MedicalDevice: Radiation: Diffusing Alpha Radiation Emitters Therapy

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

Start: Jul 2021Est. completion: Oct 20242 patients
N/ATerminated
NCT04540588Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Start: Dec 2020Est. completion: Dec 20252 patients
N/ACompleted
NCT04534127Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Start: Dec 2020Est. completion: Jan 202656 patients
N/ARecruiting
NCT03889899Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Start: Oct 2020Est. completion: Sep 202630 patients
N/ARecruiting
NCT04099446ProgenaBiomeNon-interventional

A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer

Start: Oct 2019Est. completion: Dec 2020
N/AWithdrawn
NCT03737734Alpha Tau MedicalRadiation: Diffusing Alpha Radiation Emitters Therapy

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Start: Dec 2018Est. completion: Dec 202530 patients
N/AActive Not Recruiting

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
16m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
16m ago

Office Administrator

SystImmune
16m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
26m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
30m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
30m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 120 patients
2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)